Le Lézard
Classified in: Health
Subject: VET

Bob Woodruff Foundation Offers Guidance on Complementary and Integrative Health Practices for Veterans with PTSD


NEW YORK, Feb. 6, 2024 /PRNewswire/ -- As part of its work to support the mental and physical wellness of veterans and service members, the Bob Woodruff Foundation (BWF) has published "Understanding the Role of Complementary and Integrative Health (CIH) in treating PTSD." The latest BWF research brief addresses the benefits and limitations of CIH practices such as acupuncture, biofeedback, and clinical hypnosis when used with conventional approaches.

The report outlines the conditions in which CIH practices are most likely to be successful. These include in concert with evidence-based clinical mental health care or when used for patients with minor PTSD symptoms or those who have not improved with traditional treatment. In addition, while CIH practices such as biofeedback and relaxation techniques can be popular among veterans, especially those with PTSD, there is not strong evidence to support these practices as primary treatments.

"We know there is a need for guidance and support on this issue. Veterans with PTSD are 25 percent more likely than those without to use CIH practices. It is important that providers present CIH accurately, as an additional tool for reducing PTSD symptoms when used with evidence-based therapy," says AnneMarie Dougherty, CEO at the Bob Woodruff Foundation.

Other key findings from the brief:

The Department of Veterans Affairs (VA) recently approved some CIH practices as part of its standard package of medical benefits for veterans. VA will cover these treatments at VA facilities or in non-VA settings when a veteran's care team determines the treatments are clinically necessary. For primary treatment, the VA and Department of Defense's latest guidelines recommend conventional trauma-focused psychotherapies. These include prolonged exposure, cognitive processing therapy, and eye-movement desensitization and reprocessing.

About The Bob Woodruff Foundation

The Bob Woodruff Foundation (BWF) was founded in 2006 after reporter Bob Woodruff was wounded by a roadside bomb while covering the war in Iraq. Since then, BWF has led an enduring call to action for people to stand up for heroes and meet the emerging and long-term needs of today's veterans, including mental health, caregiver support, food insecurity, and service-connected fertility issues. To date, BWF has invested over $159 million to ensure that our nation's veterans, service members, and their families have stable and successful futures. For more information, visit bobwoodrufffoundation.org

Contact:
Maicie Calvert
561 764 5877
372453@email4pr.com

SOURCE Bob Woodruff Foundation


These press releases may also interest you

at 16:15
GE HealthCare , is announcing that its Vice President and Chief Financial Officer, Jay Saccaro will be presenting at the following upcoming investor conferences. Bank of America Securities 2024 Healthcare Conference in Las Vegas ? May 14, 2024 at...

at 16:15
Revance Therapeutics, Inc. , today announced that the company will release first quarter 2024 financial results on Thursday, May 9, 2024, after the close of market. Revance will host a corresponding conference call and a live webcast at 1:30 p.m. PT...

at 16:10
Puma Biotechnology, Inc. , a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2024. Unless otherwise stated, all comparisons are for the first quarter 2024 compared to the first quarter 2023. Product...

at 16:10
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the second quarter of fiscal 2024 ended...

at 16:10
Vir Biotechnology, Inc. today provided a corporate update and reported financial results for the first quarter ended March 31, 2024. "We are excited to share important data from our Phase 2 chronic hepatitis delta SOLSTICE trial at the upcoming...

at 16:10
Arcus Biosciences , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the...



News published on and distributed by: